Foye's Principles of Medicinal chemistry

[Direct Download] Foye’s Principles of Medicinal chemistry 7th edition PDF Free

The 7th edition of Foye’s Principles of Medicinal chemistry is available free to download in pdf format. Our valuable visitors can download this e-book free of cost. We always try to share free content for educational purposes. Foye’s Principles of Medicinal chemistry 7th edition came with changes and up-gradation like, new material for students, updated chapters that meets the needs of today’s medicinal chemistry courses.

This latest edition offers an unparalleled presentation of drug discovery and pharmaceutical agents, integrating the principles of pharmaceutical chemistry with pharmacology, pharmacokinetics and clinical pharmacy.
All chapters are written by an international team of distinguished researchers and academics. Careful editing ensures smooth, full style and formatting and easy navigation throughout the text.

 

About this Book

Now have a look at the preface of Foye’s Principles of Medicinal chemistry 7th edition which you can download free in pdf format at the end of this post with the direct download link.  Medicinal chemistry is central to modern drug discovery and development.

For most of the 20th century, the majority of drugs were discovered either by identifying the active ingredient in traditional natural remedies, by rational drug design, or by serendipity. As we have moved into the 21st century, drug discovery has focused on drug targets and high-throughput screening of drug hits and computer-assessed drug design to fill its drug pipeline. Medicinal chemistry has advanced during the past several decades from not only synthesizing new compounds but to understanding the molecular basis of a disease and its control, identifying biomolecular targets implicated as disease-causing, and ultimately inventing specific compounds (called “hits”) that block the biomolecules from progressing to an illness or stop the disease in its tracks. Medicinal chemists use structure-activity relationships to improve the “hits” into “lead candidates” by optimizing their selectivity against the specific target, reducing drug activity against non-targets, and ensuring appropriate pharmacokinetic properties involving drug distribution and clearance.

 

These are tough times for the drug industry, as companies are looking at diminishing pipelines of potential new drugs, growing competition from generic versions of their drugs and increasing pressure from regulatory agencies to ensure that products are both safe and more effective than existing drugs. With the completion of the sequencing of the human genome, there are now greater challenges facing the drug industry for applications of new technologies in discovery and development. The number of drug targets once considered to be less than 500, has doubled and is expected to increase tenfold. Diseases that were once thought to be caused by a single pathology are now known to have differing etiologies requiring highly specific medications. In order to maintain its pipeline of new drugs, the drug industry is integrating biopharmaceuticals, such as therapeutic antibodies (e.g., in the treatment of arthritis), along with small-molecule drugs. As the drug industry undergoes reform, drug companies are developing collaborations with academia for new sources of drug molecules.

The editors of this textbook are all medicinal chemists, and our approaches to editing this seventh edition of Foye’s Principles of Medicinal Chemistry are influenced by our respective academic backgrounds. We believe that our collaboration on this textbook represents a melding of our perspectives that will provide new dimensions of appreciation and understanding for all students.

As defined by IUPAC, medicinal chemistry is a chemistry-based discipline, involving aspects of the biological, medical and pharmaceutical sciences. It is concerned with the invention, discovery, design, identification and preparation of biologically active compounds, the study of their metabolism, the interpretation of their mode of action at the molecular level and the construction of structure-activity relationships (SAR), which is the relationship between chemical structure and pharmacological activity for a series of compounds.

 

 

 

You can aslo download more medical and pharmaceuticals free books here

 

 

ORGANIZATIONAL PHILOSOPHY

The organizational approach taken in this textbook builds from the principles of drug discovery, physicochemical properties of drug molecules, and ADMET (absorption distribution-metabolism-excretion-toxicity) to their integration into therapeutic substances with application to patient care. Our challenge has been to provide a comprehensive description of drug discovery and pharmacodynamic agents in an introductory textbook. To address the increasing emphasis in U.S. pharmacy schools on integrating medicinal chemistry with pharmacology and clinical pharmacy and the creation of one-semester principle courses, we organized the book into four parts: Part I: Principles of Drug Discovery; Part II: Drug Receptors Affecting Neurotransmission and Enzymes as Catalytic Receptors; Part III: Pharmacodynamic Agents (with further subdivision into drugs affecting different physiologic systems); and Part IV: Disease State Management. Parts I and II are designed for a course focused on principles of drug discovery and Parts II through IV are relevant to integrated courses in medicinal chemistry/pharmacodynamics/pharmacotherapeutics.

 

What is updated in 7th Edition?

The pharmacist sits at the interface between the healthcare system and the patient. The pharmacist has the responsibility for improving the quality of life of the patient by assuring the appropriate use of pharmaceuticals. To do this appropriately, the pharmacist must bring together the basic sciences of chemistry, biology, biopharmaceutics and pharmacology with the clinical sciences. In an attempt to relate the importance of medicinal chemistry to the clinical sciences, each of the chapters in Part II, Pharmacodynamic Agents, through Part IV, Disease State Management, includes the following:

A clinical significance section: At the beginning of most chapters, a practising clinician has provided a statement of the clinical significance of medicinal chemistry to the particular therapeutic class of drugs

A clinical scenario section:  At the beginning of the chapters in Part III and IV the clinician has provided a brief clinical scenario (mini-case) or real-life therapeutic problem related to the disease state under consideration. A solution to the case or problem appears at the end of the chapter along with the medicinal chemist’s analysis of the solution.
 
 
 

About Author:

This great book Foye’s Principles of Medicinal chemistry is written by 

  • Tuomas L. Lemke, PHD
  • Professor Emeritus
  • College of Pharmacy
  • University of Houston
  • Houston, Texas
 
 
 
 
Read Online

 
 

Leave a Reply

Your email address will not be published. Required fields are marked *